ClinicalTrials.Veeva

Menu

Intermittent Oral Tube in Alzheimer's Patients

C

Copka Sonpashan

Status

Not yet enrolling

Conditions

Alzheimer Disease

Treatments

Device: Nasogastric tube
Device: Intermittent Oral-esophageal Tube Feeding
Behavioral: Conventional Care

Study type

Interventional

Funder types

Other

Identifiers

NCT06328829
IOE Alzheimer

Details and patient eligibility

About

This is a prospective multicenter study with Alzheimer's patients with dysphagia. Patients enrolled are randomly divided equally into the observation group and the control group. All patients receive conventional care, and the observation group received Intermittent Oral-esophageal Tube Feeding while the control group received Nasogastric Tube Feeding for enteral nutrition support. Baseline information (demographics, medical history, etc.), nutritional status at admission and after treatment, depression, dysphagia, and quality of life after treatment are compared.

Full description

The Alzheimer's disease in the elderly exhibits the high prevalence.This is a prospective multicenter study with Alzheimer's patients with dysphagia. Patients enrolled are randomly divided equally into the observation group and the control group. All patients receive conventional care, and the observation group received Intermittent Oral-esophageal Tube Feeding while the control group received Nasogastric Tube Feeding for enteral nutrition support. Baseline information (demographics, medical history, etc.), nutritional status at admission and after treatment, depression, dysphagia, and quality of life after treatment are compared.

Enrollment

80 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age between 18 years and 85 years, meeting the diagnosis of Alzheimer's Disease.
  • presence of no contraindication for enteral nutrition.
  • with dysphagia verified by Imaging materials.
  • with stable vital signs and no severe liver or kidney dysfunction, metabolic disorders, cardiovascular diseases, or multiple complications
  • Minimum Mental State Examination ranging from 10-26

Exclusion criteria

  • unable to cooperate in completing treatment and assessment due to personal reasons or other disorders.
  • complicated with other intracranial lesions, such as stroke.
  • abnormal structure of swallowing-related organ and tissue.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

80 participants in 2 patient groups

Conventional Care+Intermittent Oral-esophageal Tube Feeding
Experimental group
Description:
During the 15-day treatment, both groups of patients are hospitalized, while conventional care and enteral nutrition support are provided to the two groups. The observation group receives Intermittent Oral-esophageal Tube Feeding for enteral nutrition support
Treatment:
Behavioral: Conventional Care
Device: Intermittent Oral-esophageal Tube Feeding
Conventional Care+Nasogastric tube
Active Comparator group
Description:
During the 15-day treatment, both groups of patients are hospitalized, while conventional care and enteral nutrition support are provided to the two groups. The control group receives Nasogastric Tube Feeding for enteral nutrition support
Treatment:
Behavioral: Conventional Care
Device: Nasogastric tube

Trial contacts and locations

0

Loading...

Central trial contact

Lavie Ce

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems